Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: The impact of pharmacokinetic gene profiles across human cancers

Fig. 5

Low expression of drug target genes for administered therapies is associated with patient survival in a mechanism-dependent manner. For specific therapies and per-cancer, examples with at least five patients in each group are shown. Data are presented as in previous figures; N, the number of patients administered the therapy; M, the number of patients with low levels of at least one of the therapy’s targets

Back to article page